Lohocla-201

N/A

Report date: 2025/10/25 20:00:07
NME

Base Information

Drug NameLohocla-201
Drug Alias NameKindolor®
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit modulatorsSodium channel protein type X alpha subunit modulatorsδ-opioid receptor agonists +[4] 
TargetsSodium channel protein type IX alpha subunitδ-opioid receptorGlutamate [NMDA] receptor +[4] 
Therapy Area/IndicationsAnxiety DisordersChronic PainPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLohocla Research Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLohocla Research CorporationLohocla Research Corp
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersChronic PainPain

Other Information

ATC CodeN/A
Related LinksN/A